Aptamers are short single-stranded DNA or RNA molecules that fold into 3D structures capable of binding targets (proteins, small molecules, cells, or even complex particles) with high specificity and affinity. “Aptamer methods” usually refers to the full pipeline: library design → selection (SELEX) → enrichment monitoring → sequencing & bioinformatics → candidate optimization → biophysical/functional validation → stability engineering. Modern platforms improve speed and hit quality by combining smarter selection pressures with microfluidics and next-generation sequencing.
Start with a random oligonucleotide library (often 10^13–10^15 unique sequences)
Incubate library with the target
Partition bound vs unbound sequences
Elute binders
Amplify (PCR for DNA; RT-PCR + transcription for RNA)
Repeat iterative rounds with increasing stringency until enrichment is achieved
Why it works: each round increases the fraction of sequences that can bind under the imposed conditions (buffer, temperature, competitor molecules, etc.). Why it’s hard: classical SELEX can be slow, labor intensive, and prone to amplification bias—hence the rise of “advanced SELEX” platforms.
Selection success often depends less on the target itself and more on how you shape the evolutionary pressure:
Counter-SELEX / negative selection: remove sequences that bind off-targets or matrices (beads, membranes, tags).
Competitor-driven selection: add related molecules/serum proteins to force specificity.
Kinetic selection: shorten binding time to favor fast on-rates; harsher washing to favor slow off-rates. (Common strategy described across SELEX method reviews.)
CE-SELEX separates free nucleic acids from target-bound complexes by capillary electrophoresis, exploiting high-resolution partitioning. A key advantage discussed in CE-SELEX overviews is dramatically fewer rounds compared with classical SELEX under many conditions.
Microfluidic designs shrink volumes, accelerate mixing/partitioning, and enable automation—often improving throughput and selection efficiency. Reviews emphasize microfluidics as a major contributor to faster, more scalable aptamer screening.
Cell-SELEX selects aptamers against targets presented in their native membrane context—even when the molecular target is unknown. It’s widely used when purified targets are unavailable or poorly folded ex vivo, with dedicated discussions of its strengths/limitations in the literature.
Instead of only cloning a few sequences at the end, HTS reads millions of sequences across rounds, enabling:
early identification of promising families
enrichment tracking
motif discovery
detection of amplification artifacts
This “SELEX + NGS” direction is repeatedly highlighted as a leap in precision and throughput.
Chemical diversity can be introduced during selection (not only after), expanding the chemical interactions aptamers can make. Reviews cover mod-SELEX strategies broadly, and recent method papers describe selection systems compatible with extensive sugar/base modifications.
DNA aptamers: simpler amplification, often robust
RNA aptamers: richer folding and potential binding modes, but need transcription steps and are generally more nuclease-sensitive without modification
Modern aptamer methods increasingly avoid “purely random” libraries and instead:
bias nucleotide frequencies
embed partially structured scaffolds
tune random region length
These concepts are discussed as methodological levers in chemical modification / design-focused reviews.
After sequencing, candidates are often shortened to the minimal binding core to:
reduce synthesis cost
improve folding consistency
lower non-specific interactions
This is a standard post-SELEX optimization concept across aptamer methodology reviews.
Aptamers can degrade quickly in biological fluids and may clear rapidly via renal filtration; chemical modifications aim to improve stability and in vivo behavior:
2′-fluoro (2′-F), 2′-O-methyl (2′-OMe) (common ribose modifications)
LNA / other constrained analogs
End-capping / exonuclease protection
PEGylation or other conjugation strategies (context-dependent)
Aptamer methods are incomplete without binding and stability validation. Common characterization approaches include:
SPR (surface plasmon resonance) for kinetic binding (kon/koff)
MST (microscale thermophoresis) for solution-phase affinity
ITC (isothermal titration calorimetry) for thermodynamics (ΔH/ΔS)
broader “binding affinity assay” workflows and comparative assay discussions exist across method papers and reviews
Stability methods typically assess:
nuclease resistance (serum/plasma incubation)
thermal stability / melting behavior
structural integrity under buffer and temperature changes
Even strong aptamer candidates can fail due to methodological issues:
Amplification bias: PCR over-enrichment of sequences that amplify well, not bind well
Matrix binders: sequences that bind beads/membranes instead of the target
Non-specific electrostatic binders: sequences that “stick” to many proteins in low-salt buffers
Reproducibility gaps: poor control of ionic strength, temperature, incubation time, and wash stringency
These challenges are repeatedly highlighted as factors influencing successful aptamer selection and translation.
Modern aptamer methods are best viewed as an evolutionary engineering pipeline: advanced SELEX (microfluidic, CE-SELEX, cell-SELEX, HTS-assisted) generates better candidates faster, while post-SELEX optimization (truncation + chemical modification) and rigorous characterization (affinity + kinetics + stability) turn sequences into reliable diagnostic or therapeutic binding reagents.
Screening of aptamers and their potential application in targeted diagnosis and therapy of liver cancer
Aptamer Screening- Current Methods and Future Trend towards Non-SELEX Approach
Aptamer Discovery Platform
Aptamer Screening Services for Peptide
selexkmdbio-Cell Nucleic Acid Aptamer Screening Service
Current Status and Future Directions of Aptamer Development
Major Application Fields of Aptamers
Key Characteristics and Working Principle of Aptamers
aptamer
Aptamer screening via SELEX for molecular recognition
APTAMER SCREENING METHODS
Aptamer screening technologies
Toggle-SELEX Aptamer Screening Service
Negative Aptamer Selection- A Practical Guide to Improving Aptamer Specificity in SELEX
selexkmdbio-Cell Nucleic Acid Aptamer Screening Service
Aptamer Screening- Current Methods and Future Trend towards Non-SELEX Approach
Aptamer Screening Service-Subtractive SELEX
Aptamer Screening Service-Counter SELEX
Aptamer Screening Service-HT-SELEX
Aptamer Screening Service-NGS-SELEX
Aptamer Screening Service-Multi-Round SELEX Screening
Whole Cell-SELEX Aptamer Screening Service
Membrane Protein Aptamer Screening Service
Aptamer Screening Service for Drug Discovery
Aptamer Live Cell SELEX Service
Classical SELEX Service for Aptamer
Aptamer Selection and Identification
Aptamer Screening Process and Applications Overview